MAGNEX® Indications


CA-IAI, community-acquired intra-abdominal infection; ESBL, extended spectrum beta-lactamase; IAI, intra-abdominal infection; RTI, respiratory tract infection; UTI, urinary tract infection.

1. Local Product Document. Magnex®. version LPDMGX042020.
2. Sudhaharan S, Kanne P, Vemu L, Chavali P, Desmukha SR, Nagari B. Bacteriological profile of intra-abdominal infections in a tertiary care hospital. Iran J Microbiol. 2018;10(4):208-214.

PP-MGX-IND-0399. 09 December 2021
Please click on Prescribing Information link to view safety and adverse events information of MAGNEX®
For the use only of registered medical practitioner, or a hospital or a laboratory.